Transnasal Therapy for Acute Migraine Attack

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

August 15, 2018

Primary Completion Date

October 31, 2019

Study Completion Date

November 15, 2019

Conditions
Migraine Disorders
Interventions
OTHER

Humidified oxygen

Delivering humidified oxygen at 15 liters per minute through the nose in a blinded fashion using a nasal cannula.

OTHER

Dry oxygen

Delivering dry oxygen at 15 liters per minute through the nose in a blinded fashion using a nasal cannula.

OTHER

Humidified air

Delivering humidified air at 15 liters per minute through the nose in a blinded fashion using a nasal cannula.

OTHER

Dry air

Delivering dry air at 15 liters per minute through the nose in a blinded fashion using a nasal cannula.

Trial Locations (1)

21224

Clinical Trials Unit, Johns Hopkins Bayview (JHU ICTR), Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT04129567 - Transnasal Therapy for Acute Migraine Attack | Biotech Hunter | Biotech Hunter